Showing 641 - 660 results of 26,678 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.83s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645
  6. 646
  7. 647
  8. 648
  9. 649
  10. 650
  11. 651
  12. 652

    Data Sheet 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.pdf by Yan Liu (25061)

    Published 2025
    “…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”
  13. 653

    Data Sheet 2_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

    Published 2025
    “…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”
  14. 654

    Table 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

    Published 2025
    “…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”
  15. 655

    Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (<i>S</i>, <i>Se</i>) and Their Azole Derivatives against Chagas Disease by Mercedes Rubio-Hernández (20036142)

    Published 2024
    “…Three compounds were selected, based on their activity against the intracellular amastigotes (EC<sub>50</sub> < 1 μM, SI > 10) and cruzain (IC<sub>50</sub> < 100 nM, SI > 5.55) which compared favorably with the approved drug, Benznidazole, and the well-established cruzain inhibitor K777. …”
  16. 656

    Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (<i>S</i>, <i>Se</i>) and Their Azole Derivatives against Chagas Disease by Mercedes Rubio-Hernández (20036142)

    Published 2024
    “…Three compounds were selected, based on their activity against the intracellular amastigotes (EC<sub>50</sub> < 1 μM, SI > 10) and cruzain (IC<sub>50</sub> < 100 nM, SI > 5.55) which compared favorably with the approved drug, Benznidazole, and the well-established cruzain inhibitor K777. …”
  17. 657
  18. 658

    Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

    Published 2017
    “…Uremic serum increased the intracellular expression of IL-6, IFN-γ, TLR7, TLR9, VDR, CYP27b1 and CYP24a1. Treatment with 25 or 1,25 vitamin D decreased IL-6 and TLR9. …”
  19. 659
  20. 660